Actinogen Medical Banner Image

Actinogen Medical

  • Ticker ACW
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Actinogen Medical Logo Image
  • 1-10 Employees
  • Based in Sydney, Australia
Actinogen Medical is an ASX-listed biotechnology company developing novel therapies for neurological diseases associated with dysregulated brain cortisol.Actinogen Medical’s lead compound, Xanamem®, has been specifically designed to reduce production of intracellular cortisol - the stress hormone - through the inhibition of the 11β-HSD1 enzyme in the brain.
Actinogen Medical

Most Recent Annual Report

Actinogen Medical
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports